Emergent Biosolutions Inc’s recent filing unveils that its Director Fowler Neal Franklin unloaded Company’s shares for reported $0.2 million on Mar 12 ’25. In the deal valued at $5.83 per share,35,000 shares were sold. As a result of this transaction, Fowler Neal Franklin now holds 101,100 shares worth roughly $0.49 million.
Then, Zoon Kathryn C sold 10,000 shares, generating $57,300 in total proceeds. Upon selling the shares at $5.73, the Director now owns 44,482 shares.
Before that, Fowler Neal Franklin bought 35,000 shares. Emergent Biosolutions Inc shares valued at $204,005 were divested by the Director at a price of $5.83 per share.
H.C. Wainwright initiated its Emergent Biosolutions Inc [EBS] rating to a Buy in a research note published on December 30, 2024; the price target was $15. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. The Benchmark Company also remained covering EBS and has increased its forecast on March 07, 2024 with a “Buy” recommendation from previously “Hold” rating.
Price Performance Review of EBS
On Monday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock jump 4.29% to $4.86. Over the last five days, the stock has lost -15.18%. Emergent Biosolutions Inc shares have fallen nearly -49.16% since the year began. Nevertheless, the stocks have risen 87.64% over the past one year. While a 52-week high of $15.10 was reached on 01/24/25, a 52-week low of $1.82 was recorded on 03/28/25. SMA at 50 days reached $7.95, while 200 days put it at $8.72.
Levels Of Support And Resistance For EBS Stock
The 24-hour chart illustrates a support level at 4.53, which if violated will result in even more drops to 4.21. On the upside, there is a resistance level at 5.32. A further resistance level may holdings at 5.79. The Relative Strength Index (RSI) on the 14-day chart is 28.65, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.69, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.97%. Stochastics %K at 13.81% indicates the stock is a buying.
How much short interest is there in Emergent Biosolutions Inc?
A steep rise in short interest was recorded in Emergent Biosolutions Inc stocks on 2025-03-14, growing by 2.06 million shares to a total of 9.16 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 7.09 million shares. There was a rise of 22.51%, which implies that there is a positive sentiment for the stock.
